This study found a high incidence of asymptomatic and paroxysmal atrial fibrillation following patent foramen ovale closure, with a significant proportion of episodes occurring beyond 30 days post-procedure.
The PROTECT IV trial; Denmark’s shift in routine prasugrel or ticagrelor use; OCT vs angiography in ACS patients; blood pressure changes after renal denervation; renal denervation and kidney disease; a concertina effect mimicking plaque rupture on OCT; and more...
The article provides a practical overview of the use of drug-coated balloons (DCBs) in the treatment of coronary bifurcation lesions, exploring their potential advantages, integration into provisional stenting strategies, and current evidence supporting their use.